Pmgc Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pmgc Holdings Inc's ROI in the second quarter of 2026?
Pmgc Holdings Inc recorded a cumulative net loss of $-13 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -99.21%.

Within the Healthcare sector 153 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3816 to 3953.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	58.14 %	46.82 %	54.74 %	106.11 %	-69.01 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	21	15	9	9	9
Return On Investment (TTM)	-99.21 %	-105.17 %	-86.06 %	-77.04 %	-65.23 %
ELAB's Overall Ranking	# 3953	# 3816	# 0	# 0	# 0
Seq. Investment Change TTM	28.72 %	17.3 %	3.53 %	1.17 %	19.5 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-13	-11	-8	-7	-6

ELAB Company Profile >> Back to ELAB Roi Comparisons >> See Annual ELAB Return On Investment

Return On Investment ELAB's Ranking
Within:	No.
Industry	# 54
Sector	# 154
Overall	# 3953

Return On Investment Statistics
High	Average	Low
-65.23 %	-87.08 %	-105.17 %
(Jun 30 2025)		(Mar 31 2026)

Financial Statements
Pmgc Holdings Inc's II. Quarter Investments	$ 21 Millions	ELAB's Balance sheet
Pmgc Holdings Inc's II. Quarter Income	$ -3 Millions	Quarterly ELAB's Income Statement
ELAB's Income by Division		See ELAB's Income by Division

ELAB Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2022) 2023
Total Investments in Millions	9	8	1	0	0
Y / Y Investment Growth	15.93 %	490.49 %	-	-	-
Net Income in Millions	-8	-6	-2	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-86.8 %	-81.12 %	-138.07 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ELAB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ELAB's Competitors
Subscribers only: Roi for Pmgc Holdings Inc's Suppliers
Subscribers only: Return On Investment for ELAB's Customers

Other Ratios
ELAB's Roa	ELAB's Inventory Turnover Ratio	ELAB's Growth Rates	ELAB's Dividend Statistics
	ELAB's Profitability Ratios	ELAB's Asset Turnover Ratio	ELAB's Dividend Growth
ELAB's Roe	ELAB's Valuation Ratios	ELAB's Financial Strength Ratios	ELAB's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:42:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.